[Comparison of the effectiveness of mono- and polychemotherapy for murine lymphosarcoma, resistant to apoptosis induction].
Strain-specific murine lymphosarcoma RLS, resistant to apoptosis induction, was used to demonstrate that polychemotherapy (cyclophosphamide+adriamycin+cisplatin) failed to gain any significant advantage over monotherapy with adequate doses of those drugs
Kaledin
V I
VI
Popova
N A
NA
Andreeva
E M
EM
D000818:Animals; D000970:Antineoplastic Agents / Q000494:pharmacology* / Q000627:therapeutic use; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000494:pharmacology; D017209:Apoptosis / Q000187:drug effects; D002945:Cisplatin / Q000494:pharmacology; D003520:Cyclophosphamide / Q000494:pharmacology; D004317:Doxorubicin / Q000494:pharmacology; D019008:Drug Resistance, Neoplasm; D008228:Lymphoma, Non-Hodgkin / Q000188:drug therapy* / Q000473:pathology; D008297:Male; D051379:Mice; D008808:Mice, Inbred CBA; D012074:Remission Induction
D000970:Antineoplastic Agents; D004317:Doxorubicin; D003520:Cyclophosphamide; D002945:Cisplatin